Among the identified genes, the most interesting are NDUFS6, NDUFA9, MT-ND5, SDHA, NDUFB10, NDUFB9, NDUFB6, NDUFA8, NDUFA10, MDH2, CS, PDHA1, TIMM17A, TOMM40, HSPD1, PHB, CYC1, and COX5A, as their products have been shown to be involved in regulating drug resistance in tumor cells and/or the antitumor immune response, and may also be associated with the activation of inflammatory signaling pathways [41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75]. The gene discussed is NDUFB10; the disease is neoplasm.